Achard syndrome

From WikiMD's WELLNESSPEDIA

Achard syndrome
Synonyms
Pronounce
Specialty Endocrinology
Symptoms Diabetes mellitus, hirsutism, menstrual irregularities
Complications N/A
Onset
Duration
Types
Causes Genetic mutation
Risks
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Cushing's syndrome, Polycystic ovary syndrome
Prevention
Treatment Hormone replacement therapy, insulin therapy
Medication
Prognosis
Frequency Rare
Deaths


Achard syndrome is a rare genetic disorder characterized by a combination of endocrine and metabolic abnormalities. It is also known as diabetes in bearded women or diabetes of bearded women due to its distinctive presentation in affected individuals.

Presentation[edit]

Achard syndrome typically presents in postmenopausal women with a combination of diabetes mellitus and hirsutism. The main features of the syndrome include:

Pathophysiology[edit]

The exact cause of Achard syndrome is not well understood. It is believed to involve a combination of genetic and environmental factors that affect the endocrine system. The syndrome is associated with insulin resistance, which leads to hyperglycemia and the development of diabetes mellitus. The hirsutism observed in affected individuals is thought to be due to increased levels of androgens.

Diagnosis[edit]

The diagnosis of Achard syndrome is based on the clinical presentation and laboratory findings. Key diagnostic criteria include:

Treatment[edit]

There is no specific cure for Achard syndrome. Treatment focuses on managing the symptoms and preventing complications. This may include:

Prognosis[edit]

The prognosis for individuals with Achard syndrome varies depending on the severity of the symptoms and the effectiveness of the treatment. With proper management, individuals can lead relatively normal lives, although they may be at increased risk for complications related to diabetes mellitus and cardiovascular disease.

See also[edit]


This endocrine system related article is a stub.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.